In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Livongo Health goes public netting $380mm on Nasdaq

Executive Summary

Livongo Health Inc. netted $380mm through its oversubscribed initial public offering of 14.6mm common shares (including full exercise of the overallotment) at $28 each on the Nasdaq. The company had planned to sell 10.7mm shares between $20 and $26.

Deal Industry
  • Digital Health
  • Medical Devices
  • Medical Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies